Clinical Trial Update: Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bicalutamide and dutasteride versus standard care for prostate cytoreduction prior to brachytherapy in prostate cancer; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Lower Urinary Tract Symptoms
• Prostate Cancer

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• bicalutamide (bicalutamide)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Prostate Cancer, Erectile Dysfunction | Phase 2 | Status: COMPLETED